CAS RN: 6191-71-5
cis-4-Hepten-1-ol
Product Availability
Choose a grade to view its available package options.
3 package records 3 with current stock 1 grade group
Grade
≥95% (3)
In stock only
Batch No. Package Availability Inquiry
Batchno.20250831
1ml
In stock
Inquiry
Batchno.20260510
25ml
In stock
Inquiry
Batchno.20251122
5ml
In stock
Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 25g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 6191-71-5
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
25g
≥95%
0
Out of Stock
Shenzhen
Inquiry
6191-71-5 / hept-4-en-1-ol
Standard CAS: 6191-71-5
Multi CAS: Yes
Basic Information
copy
CAS
6191-71-5 copy
Multi CAS
Yes copy
Molecular Formula
C7H14O copy
Molecular Weight
114.190000 copy
Exact Mass
114.104465 copy
InChI
InChI=1S/C7H14O/c1-2-3-4-5-6-7-8/h3-4,8H,2,5-7H2,1H3 copy
InChIKey
CUKAXHVLXKIPKF-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
8 copy
Fraction Csp3
0.71 copy
Rotatable bonds
4 copy
H-bond acceptors
1 copy
H-bond donors
1 copy
Molar refractivity
35.75 copy
TPSA
20.23 copy
LogP / Solubility
WLOGP
1.73 copy
MLOGP
1.51 copy
XLogP3
1.7 copy
Consensus LogP
1.65 copy
Log S (ESOL)
-1.37 copy
Class (ESOL)
Soluble copy
Log S (Ali)
-1.74 copy
Class (Ali)
Soluble copy
Log S (SILICOS-IT)
-2.31 copy
Class (SILICOS-IT)
Moderately soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.19 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
No copy
Bioavailability score
0.55 copy
Brenk alerts
1 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy